The classification of the patient cohort in low and high GDF11 expression revealed that those patients with high levels of GDF11 showed a higher frequency of lymph node metastasis, more deaths and lower survival. Here, GDF11 is linked to metastatic malignant neoplasm in the lymph nodes.